Skip to main content

Table 3 Reported symptoms in Bartonella-seropositive and Bartonella-seronegative patients

From: Bartonella spp. seroprevalence in tick-exposed Swedish patients with persistent symptoms

Symptoms

Patients positive for anti-Bartonella spp. IgG antibodies (n = 16)

Patients negative for anti-Bartonella spp. IgG antibodies (n = 32)

Total (n = 48)

Fatigue

15 (94%)

27 (84%)

42 (88%)

Sleeping problems

11 (69%)

25 (78%)

36 (75%)

Headache

9 (56%)

24 (75%)

33 (69%)

Cognitive symptoms

10 (63%)

28 (88%)

38 (79%)

Dizziness

5 (31%)

19 (59%)

24 (50%)

Vertigo/motion sickness

3 (19%)

12 (38%)

15 (31%)

Falling sensation

3 (19%)

8 (25%)

11 (23%)

Stinging/burning sensation

7 (44%)

14 (44%)

21 (44%)

Previous Bell’s palsy (reported by patient)

1 (6%)

7 (22%)

8 (17%)

Contact hypersensitivity

5 (31%)

7 (22%)

12 (25%)

Sound sensitivity

6 (38%)

16 (50%)

22 (46%)

Other hearing symptoms

8 (50%)

19 (59%)

27 (56%)

Light sensitivity

5 (31%)

10 (31%)

15 (31%)

Other visual symptoms

7 (44%)

16 (50%)

23 (48%)

Psychiatric symptomsa

9 (56%)

24 (75%)

33 (69%)

Muscular symptoms

14 (88%)

26 (81%)

40 (83%)

Arthralgia

13 (81%)

27 (84%)

40 (83%)

Back pain

10 (63%)

20 (63%)

30 (63%)

Joint stiffness

10 (63%)

21 (66%)

31 (65%)

Neck stiffness

9 (56%)

22 (69%)

31 (65%)

Joint swelling

7 (44%)

12 (38%)

19 (40%)

Enlarged lymph nodes (reported by patient)

5 (31%)

6 (19%)

11 (23%)

Fever (reported by patient)

2 (13%)

13 (41%)

15 (31%)

  1. aIncluding depression, anxiety, mood swings and psychotic symptoms